| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 75 | 3.446 | 2.178 | 1.398 | 1.015 | 58 | 833 | 349 | 269 |
| Total Income - EUR | 0 | 75 | 3.446 | 2.178 | 1.398 | 1.015 | 58 | 833 | 349 | 269 |
| Total Expenses - EUR | 5.022 | 3.532 | 4.918 | 2.364 | 4.742 | 2.183 | 2.423 | 2.393 | 2.007 | 2.134 |
| Gross Profit/Loss - EUR | -5.022 | -3.457 | -1.472 | -186 | -3.344 | -1.167 | -2.364 | -1.560 | -1.658 | -1.865 |
| Net Profit/Loss - EUR | -5.022 | -3.459 | -1.575 | -251 | -3.386 | -1.198 | -2.366 | -1.585 | -1.658 | -1.865 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Miniclinica Medicater 4G Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 183 | 36 | 0 | 0 | 0 | 660 | 436 | 227 | 17 | 0 |
| Current Assets | 15 | 56 | 400 | 314 | 1.578 | 341 | 30 | 747 | 930 | 699 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 0 |
| Receivables | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 20 | 0 |
| Cash | 15 | 56 | 400 | 296 | 1.578 | 341 | 30 | 747 | 861 | 699 |
| Shareholders Funds | -4.977 | -8.385 | -9.819 | -9.890 | -13.084 | -14.034 | -16.089 | -17.723 | -19.327 | -21.084 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.174 | 8.478 | 10.219 | 10.204 | 14.662 | 15.034 | 16.554 | 18.697 | 20.275 | 21.783 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Miniclinica Medicater 4G Srl